GLUCOSE HEALTH, INC.: 10-Q filed 2016-12-21
What GLUCOSE HEALTH, INC. reported in its quarterly report filed 2016-12-21 (fiscal Q3 2016): 27 published measures, 75 facts as tagged in accession 0001477932-16-014204.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2016-12-21
- Fiscal period
- fiscal Q3 2016
- Accession
- 0001477932-16-014204 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All GLUCOSE HEALTH, INC. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-09-30 | 43,962 | USD | |
| At 2015-12-31 | 15,407 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-09-30 | 417,594 | USD | |
| At 2015-12-31 | 403,226 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-09-30 | -373,632 | USD | |
| At 2015-12-31 | -387,819 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-12-31 | 2,055 | USD | |
| At 2014-12-31 | 4,871 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-07-01 to 2016-09-30 | -160,819 | USD | 92 |
| 2016-01-01 to 2016-09-30 | -286,363 | USD | 274 |
| 2015-07-01 to 2015-09-30 | -49,253 | USD | 92 |
| 2015-01-01 to 2015-09-30 | -219,266 | USD | 273 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-01-01 to 2016-09-30 | -35,916 | USD | 274 |
| 2015-01-01 to 2015-09-30 | -106,537 | USD | 273 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-01-01 to 2016-09-30 | 57,500 | USD | 274 |
| 2015-01-01 to 2015-09-30 | 110,710 | USD | 273 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-01-01 to 2015-09-30 | -250 | USD | 273 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-09-30 | -6,123,557 | USD | |
| At 2015-12-31 | -5,837,194 | USD |
Basic weighted-average shares
Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-07-01 to 2016-09-30 | 2,876,993 | shares | 92 |
| 2016-01-01 to 2016-09-30 | 2,614,975 | shares | 274 |
| 2015-07-01 to 2015-09-30 | 2,132,753 | shares | 92 |
| 2015-01-01 to 2015-09-30 | 1,857,346 | shares | 273 |
Basic earnings per share
Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-07-01 to 2016-09-30 | -0.06 | USD/shares | 92 |
| 2016-01-01 to 2016-09-30 | -0.11 | USD/shares | 274 |
| 2015-07-01 to 2015-09-30 | -0.02 | USD/shares | 92 |
| 2015-01-01 to 2015-09-30 | -0.12 | USD/shares | 273 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-07-01 to 2016-09-30 | -55,556 | USD | 92 |
| 2016-01-01 to 2016-09-30 | -61,799 | USD | 274 |
| 2015-07-01 to 2015-09-30 | -34,167 | USD | 92 |
| 2015-01-01 to 2015-09-30 | -141,260 | USD | 273 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-09-30 | 43,662 | USD | |
| At 2015-12-31 | 15,107 | USD |
Interest expense
Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-07-01 to 2016-09-30 | 105,263 | USD | 92 |
| 2016-01-01 to 2016-09-30 | 224,564 | USD | 274 |
| 2015-07-01 to 2015-09-30 | 15,086 | USD | 92 |
| 2015-01-01 to 2015-09-30 | 98,579 | USD | 273 |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-09-30 | 417,594 | USD | |
| At 2015-12-31 | 403,226 | USD |
Net current accounts receivable
Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-09-30 | 11,742 | USD | |
| At 2015-12-31 | 3,150 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-07-01 to 2016-09-30 | 52,932 | USD | 92 |
| 2016-01-01 to 2016-09-30 | 80,580 | USD | 274 |
| 2015-07-01 to 2015-09-30 | 34,272 | USD | 92 |
| 2015-01-01 to 2015-09-30 | 141,602 | USD | 273 |
Net inventory
Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-09-30 | 6,418 | USD | |
| At 2015-12-31 | 8,370 | USD |
Gross profit
Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-07-01 to 2016-09-30 | -2,624 | USD | 92 |
| 2016-01-01 to 2016-09-30 | 18,781 | USD | 274 |
| 2015-07-01 to 2015-09-30 | 105 | USD | 92 |
| 2015-01-01 to 2015-09-30 | 342 | USD | 273 |
Cost of revenue
Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-07-01 to 2016-09-30 | 4,734 | USD | 92 |
| 2016-01-01 to 2016-09-30 | 279,258 | USD | 274 |
| 2015-07-01 to 2015-09-30 | 1,950 | USD | 92 |
| 2015-01-01 to 2015-09-30 | 2,290 | USD | 273 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-09-30 | 3,029,073 | shares | |
| At 2015-12-31 | 2,451,888 | shares |
Accumulated other comprehensive income or loss
Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-09-30 | -75,278 | USD | |
| At 2015-12-31 | -75,278 | USD |
Pre-tax income or loss from continuing operations
Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-07-01 to 2016-09-30 | -160,819 | USD | 92 |
| 2016-01-01 to 2016-09-30 | -286,363 | USD | 274 |
| 2015-07-01 to 2015-09-30 | -49,253 | USD | 92 |
| 2015-01-01 to 2015-09-30 | -219,266 | USD | 273 |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-07-01 to 2016-09-30 | 36,356 | USD | 92 |
| 2016-01-01 to 2016-09-30 | 45,040 | USD | 274 |
| 2015-07-01 to 2015-09-30 | 23,168 | USD | 92 |
| 2015-01-01 to 2015-09-30 | 35,646 | USD | 273 |
Nonoperating income or expense
Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-07-01 to 2016-09-30 | -105,263 | USD | 92 |
| 2016-01-01 to 2016-09-30 | -224,564 | USD | 274 |
| 2015-07-01 to 2015-09-30 | -15,086 | USD | 92 |
| 2015-01-01 to 2015-09-30 | -78,006 | USD | 273 |
Change in accounts receivable
The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-01-01 to 2016-09-30 | 8,592 | USD | 274 |
| 2015-01-01 to 2015-09-30 | 1,980 | USD | 273 |
Change in inventories
The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-01-01 to 2016-09-30 | -1,952 | USD | 274 |
| 2015-01-01 to 2015-09-30 | 9,700 | USD | 273 |
Inspect the source
- Entity
- GLUCOSE HEALTH, INC. / CIK 0001420108
- Captured
- 2026-09-20T08:03:02.532Z
- SEC response SHA-256
ef83fc563a3cad26f7c669ccda854bb2594ebf064cf3fcc8412c49070ba2bb26
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001420108.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))